WE ARE DRIVEN TO IMPROVE THE LIVES OF THOSE WHO HAVE LOST THEIR SIGHT TO RETINAL DISEASES
Every patient’s journey matters. With compassion and innovation, we work tirelessly to restore vision, improve quality of life, and fuel renewed hope for individuals affected by retinal disease. Cutting edge science means nothing if it doesn’t make a difference in the lives of patients, and that is our mission each and every day.
OUR MULTI-CHARACTERISTIC OPSIN (MCO) PLATFORM IS THE FIRST THAT HAS DEMONSTRATED AN ABILITY TO RESTORE VISION TO RETINAL DISEASE PATIENTS WITH SEVERE VISION LOSS IN CLINICAL TRIALS
Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.
OUR MISSION IS TO RESTORE VISION FOR PATIENTS
Losing vision to retinal disease is deeply life-altering—for both patients and those who love them. Everyday tasks become overwhelming, and the future can feel uncertain. We understand the emotional and physical toll, and are committed to expanding therapeutic possibilities that bring back the light of hope and renewed independence.
PATIENTS TALK ABOUT MCO-010 IN THEIR OWN WORDS
“I’ve noticed it’s been a gradual thing where I’m reaching for my magnifier in my pocket and looking for my phone and then I’ll see numbers or I’ll actually see who is calling. It’s like, WOW! They’re little things but for me it’s awesome!”
Tammie
Stargardt Disease patient and participant in the STARLIGHT Clinical Trial